AbCellera's menopause drug reduces hot flashes in mid-stage trial

ABCL•2026-08-10

Mid-stage trial results

Aug 10 (Reuters) - AbCellera ABCL.O said on Monday its experimental menopause treatment significantly reduced the frequency and severity of hot flashes in a mid-stage trial.

AbCellera's menopause drug reduces hot flashes in mid-stage trial

Mid-stage trial results

Related News

U.S. Research Roundup-Compass Minerals, Duke Energy, Tesla

Liberty Media To Offer $600 Million Convertible Senior Notes In Private Offering

Interface, Inc. <TILE.O>: Barrington Research Raises Target Price to $45 From $36

V2X wins up to $500 million US Marine Corps logistics integration support contract

BUZZ-AbCellera gains as experimental drug reduces hot flashes in mid-stage trial